Ignite Creation Date:
2025-12-24 @ 1:31 PM
Ignite Modification Date:
2026-02-22 @ 5:23 PM
Study NCT ID:
NCT02041195
Status:
COMPLETED
Last Update Posted:
2023-08-07
First Post:
2014-01-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 1b/2a Study to Evaluate Safety and Efficacy of Setmelanotide in Obese Patients
Sponsor:
Rhythm Pharmaceuticals, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RM-493-009
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None